피보험자 건강진단의 비용-편익 분석

Cost-benefit Analysis of Health Screening Test for the Insured

  • 유승흠 (연세대학교 의과대학 예방의학교실) ;
  • 손명세 (연세대학교 의과대학 예방의학교실) ;
  • 조우현 (연세대학교 의과대학 예방의학교실) ;
  • 박은철 (연세대학교 의과대학 예방의학교실) ;
  • 이영두 (연세대학교 의과대학 예방의학교실) ;
  • 이규식 (연세대학교 보건과학대학) ;
  • 전기홍 (고신대학 의학부 예방의학교실)
  • Yu, Seung-Hum (Department of Preventive Medicine & Public Health, College of Medicine Yonsei University) ;
  • Sohn, Myong-Sei (Department of Preventive Medicine & Public Health, College of Medicine Yonsei University) ;
  • Cho, Woo-Hyung (Department of Preventive Medicine & Public Health, College of Medicine Yonsei University) ;
  • Park, Eun-Cheol (Department of Preventive Medicine & Public Health, College of Medicine Yonsei University) ;
  • Lee, Young-Doo (Department of Preventive Medicine & Public Health, College of Medicine Yonsei University) ;
  • Lee, Kyu-Sik (College of Health Science, Yonsei University) ;
  • Chun, Ki-Hong (Department of Preventive Medicine, Med., Kosin College)
  • 발행 : 1989.06.01

초록

As a result of cost-benefit analysis by making a macroscopic approach to the health screening projects conducted 4 times since 1950 for the insured people of the Korea Medical Insurance Corporation, the following conclusions were reached. 1. The direct costs put into the health screening project, and the time costs which were paid by examinees or calculated in terms of social costs have been estimated. The results is that the lowest estimation was 10,337 million won and the highest 15,141 million won when a minimum of 1.5 hours of time spent and a maximum 4 hours were applied. 2. In terms of the psychiatric benefits, the lowest estimation was 5,341 million won while the highest was 5,585 million won. 3. In terms of the benefits for each kind of diseases, the lowest estimation of 37,188 million won and highest estimation of 74,383 million won have been calculated for the liver diseases. And for the cardiovascular diseases, the minimum estimation was 14,475 million won while the maximum was 20,532 million won. In case of pulmonary tuberculosis, with external effect benefits being included, the estimation ranged from the minimum of 1,649 million won to the maximum of 1,832 million won. And the estimation of benefits for diabetes mellitus and renal diseases ranged from 89 million won to 92 million won and from 4,567 million won to 7,598 million won respectively. 4. In comparing costs and benefits, as a results of comparing each highest and lowet estimation a range of minimum 46,708 million won and maximum 98,071 million won of benefits has been gained.

키워드